The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Open accessAbstract
BACKGROUND The diagnosis-specific Graded Prognostic Assessment (GPA) was published to clarify prognosis for patients with brain metastases. This study refines the existing Breast-GPA by analyzing a larger cohort and tumor subtype. METHODS A multi-institutional retrospective database of 400 breast cancer patients treated for newly-diagnosed brain metastases was generated. Prognostic factors significant for survival were analyzed by multivariate Cox regression (MCR) and recursive partitioning analysis (RPA). Factors were weighted by the magnitude of their regression coefficients to define the GPA index. RESULTS Significant prognostic factors by MCR and RPA were Karnofsky Performance Status (KPS), HER2, ER/PR status, and the interaction between ER/PR and HER2. RPA showed age was significant for patients with KPS 60–80. The median survival time (MST) overall was 13.8 months, and for GPA scores of 0–1.0, 1.5–2.0, 2.5–3.0 and 3.5–4.0 was 3.4 (n=23), 7.7 (n=104), 15.1 (n=140) and 25.3 (n=133) months, respectively (p < 0.0001). Among HER2-negative patients, being ER/PR-positive improved MST from 6.4 to 9.7 months whereas in HER2-positive patients, being ER/PR-positive improved MST from 17.9 to 20.7 months. The log-rank statistic (predictive power) was 110 for the Breast-GPA versus 55 for tumor subtype. CONCLUSIONS The Breast-GPA documents wide variation in prognosis and shows clear separation between subgroups of patients with breast cancer and brain metastases. This tool will aid clinical decision-making and stratification of clinical trials. These data confirm the effect of tumor subtype on survival and show the Breast-GPA offers significantly more predictive power than the tumor subtype alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Self-citationJemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Self-citationClassification and regression trees
Praagman, J. (1985) · European Journal of Operational Research · doi:10.1016/0377-2217(85)90321-2 · Cited by 10,053
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. G., & Byhardt, R. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,544
Self-citationMetastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
Barnholtz-Sloan, J. S., Sloan, A. E., Davis, F. G., Vigneau, F. D., Lai, P., & Sawaya, R. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.149 · Cited by 1,843
Bendell, J. C., Domchek, S. M., Burstein, H. J., Harris, L., Younger, J., Kuter, I., Bunnell, C., Rue, M., Gelman, R., & Winer, E. (2003) · Cancer · doi:10.1002/cncr.11436 · Cited by 1,320
Sperduto, P. W., Berkey, B., Gaspar, L. E., Mehta, M., & Curran, W. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citationAn Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J., Roberge, D., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 985
Self-citationNguyen, P. L., Taghian, A. G., Katz, M. S., Niemierko, A., Abi Raad, R. F., Boon, W. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4287 · Cited by 811
Lin, N. U., Claus, E., Sohl, J., Razzak, A. R., Arnaout, A., & Winer, E. P. (2008) · Cancer · doi:10.1002/cncr.23930 · Cited by 727
Self-citationIntracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2<384::aid-cncr2820480227>3.0.co;2-8 · Cited by 601
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 529
Self-citationPestalozzi, B. C., Zahrieh, D., Price, K. N., Holmberg, S. B., Lindtner, J., Collins, J., Crivellari, D., Fey, M. F., Murray, E., Pagani, O., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl064 · Cited by 413
Neurologic Complications of Cancer
Wen, P. Y., & Glantz, M. J. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00100-7 · Cited by 361
Gabos, Z., Sinha, R., Hanson, J., Chauhan, N., Hugh, J., Mackey, J. R., & Abdulkarim, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0250 · Cited by 321
Murray, K. J., Scott, C., Greenberg, H. M., Emami, B., Seider, M., Vora, N. L., Olson, C., Whitton, A., Movsas, B., & Curran, W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00341-6 · Cited by 314
Hicks, D. G., Short, S. M., Prescott, N. L., Tarr, S. M., Coleman, K. A., Yoder, B. J., Crowe, J. P., Choueiri, T. K., Dawson, A. E., Budd, G. T., et al. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213306.05811.b9 · Cited by 262
Self-citationT.Komarnicky, L., Phillips, T. L., Martz, K., Asbell, S., Isaacson, S., & Urtasun, R. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90137-s · Cited by 237
Primary breast cancer phenotypes associated with propensity for central nervous system metastases
Tham, Y., Sexton, K., Kramer, R., Hilsenbeck, S., & Elledge, R. (2006) · Cancer · doi:10.1002/cncr.22041 · Cited by 232
Heitz, F., Harter, P., Lueck, H.-J., Fissler-Eckhoff, A., Lorenz-Salehi, F., Scheil-Bertram, S., Traut, A., & Bois, A. D. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.027 · Cited by 224
Breast cancer subtypes and survival in patients with brain metastases
Nam, B.-H., Kim, S. Y., Han, H.-S., Kwon, Y., Lee, K. S., Kim, T. H., & Ro, J. (2008) · Breast Cancer Research · doi:10.1186/bcr1870 · Cited by 224
Neurologic Complications of Cancer.
Sawaya, R. E., & Ligon, B. L. (1996) · Neurosurgery · doi:10.1227/00006123-199603000-00047 · Cited by 223
Phillips, T. L., Scott, C. B., Leibel, S. A., Rotman, M., & Weigensberg, I. J. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00168-x · Cited by 185
Survival in patients with brain metastases from breast cancer
Eichler, A. F., Kuter, I., Ryan, P. D., et al. (2008) · Cancer · doi:10.1002/cncr.23468 · Cited by 154
Stemmler, H., Kahlert, S., Siekiera, W., Untch, M., Heinrich, B., & Heinemann, V. (2005) · The Breast · doi:10.1016/j.breast.2005.04.017 · Cited by 150
Sperduto, C. M., Watanabe, Y., Mullan, J. C., Hood, T. W., Dyste, G. N., Watts, C. R., Bender, G. P., & Sperduto, P. W. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/12/s14 · Cited by 142
Self-citationPhase I/II trial of accelerated fractionation in brain metastases RTOG 85-28
Sause, W. T., Scott, C., Krisch, R. E., Rotman, M., Sneed, P. K., Janjan, N. A., Davis, L. W., Curran, W. J., Choi, K. N., Selim, H., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90284-3 · Cited by 107
Self-citationMelisko, M., Moore, D. H., Sneed, P. K., et al. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9578-5 · Cited by 74
Self-citationStereotactic Radiosurgical Treatment of Cerebral Metastases Arising From Breast Cancer
Akyürek, S., Chang, E. L., Mahajan, A., et al. (2007) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000258365.50975.f6 · Cited by 68
Claude, L., Pérol, D., Ray-Coquard, I. L., Petit, T., Blay, J., Carrié, C., & Bachelot, T. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.004 · Cited by 61
Gamma knife surgery for the treatment of intracranial metastases from breast cancer
Goyal, S., Prasad, D., Harrell, F. E., et al. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.2.0218 · Cited by 53
van Dijk, M. R., Steyerberg, E. W., Stenning, S. P., Dusseldorp, E., & Habbema, J. D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601665 · Cited by 32
What Is Your Patient's GPA and Why Does It Matter? Managing Brain Metastases and the Cost of Hope
Sperduto, P. W. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.02.038 · Cited by 28
Self-citation
Cited by
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0527 · Cited by 1,425
Self-citationAchrol, A. S., Rennert, R. C., Anders, C., Soffietti, R., Ahluwalia, M. S., Nayak, L., Peters, S., Arvold, N. D., Harsh, G. R., Steeg, P. S., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0055-y · Cited by 1,034
Bachelot, T., Romieu, G., Campone, M., Diéras, V., Cropet, C., Dalenc, F., Jimenez, M., Le Rhun, E., Pierga, J.-Y., Gonçalves, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70432-1 · Cited by 737
Current approaches to the management of brain metastases
Suh, J. H., Kotecha, R., Chao, S. T., Ahluwalia, M. S., Sahgal, A., & Chang, E. L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0320-3 · Cited by 553
Self-citationSperduto, P. W., Mesko, S., Li, J., Cagney, D., Aizer, A., Lin, N. U., Nesbit, E., Kruser, T. J., Chan, J., Braunstein, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01255 · Cited by 471
Self-citation
Metadata
- Authors
- Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 82
- Issue
- 5
- Pages
- 2111-2117
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W1975088650
- Cited by
- 371
- References
- 40
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.